Press releases
- Twist Bioscience Publishes Preclinical Data Detailing Discovery of Antibody Targeting Emerging Checkpoint Inhibitor
- Twist Bioscience Announces Participation in Department of Commerce Consortium Dedicated to AI Safety
- Twist Bioscience to Present at Upcoming Investor Conferences
- Twist Bioscience Launches Multiplexed Gene Fragments to Enable High-throughput Screening Applications
- Twist Bioscience Corporation Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Twist Bioscience Reports Fiscal Second Quarter 2024 Financial Results
- Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
- Twist Bioscience Launches Pangenome Spike-in Exome Panel to Enable Advancement of Research for Diverse Populations
More ▼
Key statistics
On Friday, Twist Bioscience Corp (0ME:DUS) closed at 46.91, -3.83% below its 52-week high of 48.78, set on Jun 06, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 47.95 |
---|---|
High | 48.45 |
Low | 46.91 |
Bid | 46.31 |
Offer | 47.23 |
Previous close | 48.78 |
Average volume | 31.50 |
---|---|
Shares outstanding | 58.23m |
Free float | 57.21m |
P/E (TTM) | -- |
Market cap | 2.74bn USD |
EPS (TTM) | -3.35 USD |
Data delayed at least 15 minutes, as of Jun 07 2024 18:30 BST.
More ▼